Clinical trials
Neurological Diseases or Conditions clinical trials
Below are recruiting neurological diseases or conditions clinical trials, each written for real people, not researchers. We’re tracking 4,559 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06932185Enrolling by invitation
Ultrasound brain stimulation for movement disorders
This study tests if low-intensity ultrasound can safely change brain activity patterns in people with movement disorders like Parkinson's. You may be eligible if you already have a special brain implant that can record brain signals.
OxfordAges 18 years+ - NCT06935019Enrolling by invitation
Genome sequencing for kids with undiagnosed rare diseases
This study offers genome sequencing (a complete look at your child's DNA) to help diagnose a suspected rare disease faster. It's for children who are newly referred to the genetics clinic at SickKids or CHEO and haven't had this type of testing before.
Ottawa, OntarioAges Up to 18 years - NCT06936566RecruitingPhase 2
Ruxolitinib for graft-versus-host disease after transplant
This trial tests a drug called ruxolitinib for treating acute graft-versus-host disease (aGVHD), a common complication after a stem cell transplant. It may help control the immune reaction without using high doses of steroids.
Duarte, CaliforniaAges 18 years+ - NCT06938412Recruiting
Exercise and Fitbit for Afib patients
This study tests whether using a Fitbit activity tracker and a supportive exercise program helps people with AFib become more active. It may help you feel better and manage your heart rhythm.
New York, New YorkAges 18 years+ - NCT06935825Recruiting
Breathing muscles in severe lung disease
This study looks at how the breathing muscles work in people with very advanced COPD who are waiting for a lung transplant. It aims to understand the problems these muscles face and how that affects patients.
AmsterdamAges Any age - NCT06941012Recruiting
Measuring alpha-synuclein changes in Parkinson's disease progression
This study examines changes in alpha-synuclein, a protein linked to Parkinson's, to better understand how the disease progresses. It may help researchers learn more about Parkinson's and improve future care.
ThessalonikiAges 18–85 - NCT06929559Recruiting
How the body responds to walking when expecting pain
This study looks at how your muscles and walking pattern change when you expect a mild pain. It may help researchers understand how the body adapts to pain anticipation in healthy people.
AmiensAges 18–35 - NCT06922994RecruitingPhase 2
Testing atorvastatin for arrhythmogenic cardiomyopathy
This trial tests if a common cholesterol medicine, atorvastatin, can slow the progression of arrhythmogenic cardiomyopathy, a genetic heart condition that can cause abnormal heart rhythms. If you have this condition, joining this study may help researchers find a new way to protect your heart.
Pavia, PVAges 18 years+ - NCT06931665Recruiting
Animal therapy for patients in a minimally conscious state
This study tests whether interacting with therapy animals (like dogs) can improve brain activity and well-being in people who have a severe brain injury and are in a minimally conscious state. It aims to see if this gentle, supportive therapy may help with recovery.
BaselAges 18 years+ - NCT06924177Recruiting
Spinal cord injury diet study for wheelchair users
This study tests a special diet program for people with spinal cord injuries who use a wheelchair. It aims to see if the diet can improve health and well-being.
Dallas, TexasAges 18–65 - NCT06924593Recruiting
Shunt for carotid artery narrowing
This study tests a new device that is placed through the carotid artery in the neck to temporarily block blood flow during a procedure to open up a narrowed carotid artery. It might be an option for people who have high-risk features that make traditional surgery more challenging.
BeijingAges 18 years+ - NCT06926595RecruitingPhase 2
Stem cell transplant with low-dose chemo for graft-versus-host disease prevention
This trial tests a stem cell transplant using a reduced-intensity chemotherapy regimen and a low dose of a drug called cyclophosphamide after the transplant to help prevent graft-versus-host disease (GVHD), a common complication where donor cells attack the recipient's body. It is for people with certain blood cancers or bone marrow disorders who have a suitable donor.
Hershey, PennsylvaniaAges 18 years+ - NCT06923644Recruiting
Personalized nutrition plan to prevent metabolic disease
This study tests whether a personalized nutrition plan based on your unique metabolism can help prevent chronic metabolic diseases like type 2 diabetes. You will follow a tailored diet and have your health monitored over time.
MaastrichtAges 40–75 - NCT06931470Recruiting
Remote exercise training study for heart health
This study tests whether a remotely supervised exercise program is feasible and helpful for people who are at risk for heart disease but are not currently active enough. You would do exercises at home while being guided and monitored online.
New York, New YorkAges 45 years+ - NCT06924320RecruitingPhase 1/Phase 2
Study of two medicines for weight loss and diabetes
This study tests two investigational medications, MET233 and MET097, in people with obesity or overweight, with or without type 2 diabetes. It aims to see if the combination can help with weight loss and blood sugar control.
Cypress, CaliforniaAges 18–75 - NCT06925542RecruitingPhase 1
Study of CTX112 for adults with autoimmune disease
This trial tests an experimental cell therapy called CTX112 for people with lupus, scleroderma, or inflammatory myositis that hasn't responded well to standard treatments. The goal is to see if it's safe and if it can help control the disease.
La Jolla, CaliforniaAges 18–70 - NCT02852031Recruiting
Care program for newborns needing the Norwood procedure
This trial focuses on improving care for babies born with certain complex heart conditions where only one pumping chamber works. It is meant for babies (including unborn babies) who are planned to have the Norwood procedure, which is a common early surgery.
Birmingham, AlabamaAges Up to 1.3 years - NCT06900777Recruiting
Comparing two treatments for rapidly spreading vitiligo in children
This trial compares two medicines—oral tacrolimus and dexamethasone micro-pulse therapy—in children aged 4 to 12 whose vitiligo is spreading quickly. The goal is to see which treatment works better to stop the spread and help color return to the skin.
Xi'an, ShaanxiAges 4–12 - NCT06918990RecruitingPhase 1
CarBel for antibody-mediated rejection after kidney transplant
This study tests a new drug called CarBel to treat antibody-mediated rejection in kidney transplant patients. The goal is to see if it can help stop the rejection and protect your new kidney.
Birmingham, AlabamaAges 18–75 - NCT06920628RecruitingPhase 1
Brain scan study for long COVID neurological symptoms
This study uses a special PET scan to look at brain inflammation in people with neurological symptoms after COVID-19. It aims to understand how inflammation might be linked to ongoing problems like brain fog or memory issues.
Bethesda, MarylandAges 18–70 - NCT06920459Recruiting
Zimmer Biomet Shoulder Replacement Study
This study is testing a shoulder replacement system made by Zimmer Biomet to see how well it works for people with severe shoulder problems, like arthritis or fractures. If you qualify, you would receive the implant and be asked to come back for regular checkups to track your recovery.
PforzheimAges 20 years+ - NCT06917963Recruiting
Preventing high stoma output with omeprazole
This trial tests if a stronger dose of omeprazole can help prevent high fluid output from a new ileostomy (a surgically created opening in the belly that passes waste). If you are scheduled for surgery to create an ileostomy, you may be able to join.
Gdansk, Pomeranian VoivodeshipAges 18 years+ - NCT06912048Recruiting
How nerves signal the body in health and overweight
This study looks at how your brain sends signals to your body, comparing healthy people and those who are overweight. You'll help researchers understand differences in nerve communication.
UlmAges 18 years+ - NCT06918795Recruiting
Fontan Fitness Trial: Home exercise for better heart health
This study tests whether a home-based exercise training program can improve fitness in people with Fontan circulation. Participants will do regular aerobic exercise and be monitored for changes in heart and lung function over time.
Philadelphia, PennsylvaniaAges 10–17
Hear when a new Neurological Diseases or Conditions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neurological diseases or conditions?
- Yes. Clin2 currently lists 4,559 recruiting neurological diseases or conditions studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neurological diseases or conditions trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neurological diseases or conditions trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.